GlassScriptPrepare for your visit
Orlando R Suarez
Internal Medicine · Farmingdale, NY · NPI 1366773319
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$15,556.31
in general payments reported to CMS, 2019-2025 · $2,063 in 2025
The $2,063 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Who reported paying
General payments only, top 6 by amount.
- Abbvie INC. $3,686.16
- Astrazeneca Pharmaceuticals LP $2,929.64
- Amarin Pharma, INC. $827.67
- Salix Pharmaceuticals, A Division of Bausch Health US, LLC $634.95
- Phathom Pharmaceuticals, INC. $589.78
- Novo Nordisk INC $587.64
Drugs and devices associated with these payments
Qulipta Ubrelvy Voquezna Repatha Airsupra Breztri Impella Injectafer Linzess Trelegy Ellipta Farxiga Jardiance
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Orlando Suarez listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/243146/orlando-r-suarez